DXCM insider trading
HealthcareDEXCOM INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About DEXCOM INC
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Company website: www.dexcom.com
DXCM insider activity at a glance
FilingIQ has scored 2,505 insider transactions for DXCM since May 8, 2014. The most recent filing in our index is dated May 12, 2026.
Across the full history, 4 open-market purchases
and 1,581 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on DXCM insider trades is 61.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest DXCM Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
13F funds holding DXCM
Politicians who have traded DXCM
Frequently asked
- How many insider trades does FilingIQ track for DXCM?
- FilingIQ tracks 2,505 Form 4 insider transactions for DXCM (DEXCOM INC), covering filings from May 8, 2014 onwards. 23 of those were filed in the last 90 days.
- Are DXCM insiders net buyers or net sellers?
- Across the full Form 4 history for DXCM, 4 transactions (0%) were open-market purchases and 1,581 (63%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does DXCM insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is DXCM in?
- DEXCOM INC (DXCM) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $27.47B.
Methodology & sources
Every DXCM insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.